Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, and Large Molecule),…
QUEBEC–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation focused on developing…
SAN FRANCISCO & SALT LAKE CITY–(BUSINESS WIRE)–IDbyDNA, a metagenomics technology company setting a new standard for the identification and understanding…
DUBLIN–(BUSINESS WIRE)–The “Fabry Disease – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Fabry Disease –…
SAN FRANCISCO–(BUSINESS WIRE)–Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced…
DUBLIN–(BUSINESS WIRE)–The “Burns – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
DUBLIN–(BUSINESS WIRE)–The “Scar – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
AMSTERDAM–(BUSINESS WIRE)–Synaffix B.V., a Dutch biotechnology company exclusively focused on continued advancement of its clinical-stage antibody-drug conjugate (ADC) technology for…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new $2.3 billion unsecured revolving…
Life Sciences Executive Michael P. Gray Brings Strong Background in Biotechnology Capital Markets, Business Operations, Business Development and Alliance Management…